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Investigation of Association Between Hip Osteoarthritis
Susceptibility Loci and Radiographic Proximal Femur Shape
Claudia Lindner,1 Shankar Thiagarajah,2 J. Mark Wilkinson,2 Kalliope Panoutsopoulou,3
Aaron G. Day-Williams,4 The arcOGEN Consortium, Timothy F. Cootes,1 and Gillian A. Wallis1
Objective. To test whether previously reported hip
morphology or osteoarthritis (OA) susceptibility loci are
associated with proximal femur shape as represented by
statistical shape model (SSM) modes and as univariate
or multivariate quantitative traits.
Methods. We used pelvic radiographs and geno-
type data from 929 subjects with unilateral hip OA who
had been recruited previously for the Arthritis Research
UK Osteoarthritis Genetics Consortium genome-wide
association study. We built 3 SSMs capturing the shape
variation of the OA-unaffected proximal femur in the
entire mixed-sex cohort and for male/female-stratified
cohorts. We selected 41 candidate single-nucleotide poly-
morphisms (SNPs) previously reported as being associ-
ated with hip morphology (for replication analysis) or
OA (for discovery analysis) and for which genotype data
were available. We performed 2 types of analysis for
genotype–phenotype associations between these SNPs
and the modes of the SSMs: 1) a univariate analysis
using individual SSM modes and 2) a multivariate
analysis using combinations of SSM modes.
Results. The univariate analysis identified asso-
ciation between rs4836732 (within the ASTN2 gene)
and mode 5 of the female SSM (P5 0.0016) and between
rs6976 (within theGLT8D1 gene) andmode 7 of themixed-
sex SSM (P5 0.0003). The multivariate analysis identi-
fied association between rs5009270 (near the IFRD1 gene)
and a combination of modes 3, 4, and 9 of the mixed-sex
SSM (P5 0.0004). Evidence of associations remained sig-
nificant following adjustment for multiple testing. All 3
SNPs had previously been associated with hip OA.
Conclusion. These de novo findings suggest that
rs4836732, rs6976, and rs5009270 may contribute to hip
OA susceptibility by altering proximal femur shape.
Osteoarthritis (OA) is the most common form of
human joint disease in the Western world (1). It is a
major cause of pain and disability and has a huge socio-
economic impact, particularly in countries with an aging
population (2). There are currently no effective predic-
tive biomarkers for early OA and no available disease-
modifying therapies that alter its natural history. The
development of methods for early diagnosis as well as
new treatment options are therefore urgently needed in
order to minimize the impact of the disease.
The progression of OA is associated with radio-
graphic features such as degeneration of cartilage and
consequent joint space narrowing. Recently, detailed
morphometric analyses have been conducted to identify
key radiographic features of bone shape that contribute to
hip OA incidence and progression and that may serve as
biomarkers for presymptomatic diagnosis and treatment
evaluation (3–5). Those studies—based on radiographic
features and measurements of bone geometry—indicate
the importance of hip joint shape for susceptibility to
hip OA. However, when studies focus primarily on indi-
vidual morphometric measurements, the relationship
between global hip joint shape and OA is not taken into
account.
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Statistical shape models (SSMs) provide a global
representation of shape, which enables the quantitative
description and analysis of bone shape variation across
subjects (6). An SSM describes the shape of an object by
the sum of a mean shape and a linear combination of a
number of shape modes where the shape mode values vary
between subjects. Gregory et al first described the applica-
tion of SSMs for the analysis of proximal femur shape in
their study of osteoporotic hip fractures (7). This approach
has since been used in a number of studies to investigate
the relationship between features of proximal femur shape
and the onset, incidence, and progression of hip OA
(8–11). Such studies have also been extended to the analy-
sis of potential genetic regulators of bone shape that may
also contribute to hip OA susceptibility (12,13). All of the
above studies applied a univariate approach to analyzing
the association between genetic loci and single SSM
modes. However, a single SSM mode only describes one
direction of shape variation in the population, whereas the
overall shape consists of a subject-specific combination of
all shape model modes. Thus, approaches that capture
shape more holistically may better represent the in vivo
shape. We have therefore explored using a combination of
SSMmodes as a multivariate phenotype for genetic associa-
tion studies, applying recently published methodology for
genetic association analysis of multivariate/multiple pheno-
types (e.g., for review, see refs. 14 and 15).
OA is a complex disease with environmental and
genetic factors contributing to its susceptibility. The
genetic component of primary hip OA has been esti-
mated to be ;60% (16). There is also evidence that OA
is a highly polygenic disease with several genetic variants
contributing to its susceptibility (17). Several studies have
identified OA susceptibility loci that have been either
confirmed at a genome-wide significance level or that
are suggestive and require replication (see Supplemen-
tary Table 1, available on the Arthritis & Rheumatology
web site at http://onlinelibrary.wiley.com/doi/10.1002/art.
39186/abstract). Since the shape of the proximal femur
has previously been found to be associated with hip OA
susceptibility, the assumption of this study was that a
proportion of the genetic susceptibility to hip OA might
be due to genetic variants that contribute to proximal
femur shape. Loci that contribute to hip joint shape
may, hence, also contribute to hip OA susceptibility and
vice versa. However, limiting analyses to individual SSM
modes may decrease the power to detect such loci.
In this study, we performed genotype–phenotype
association analyses of SSM-based proximal femur
shape and candidate single-nucleotide polymorphisms
(SNPs) that had been associated previously with either
hip morphology (with the aim of replicating previous
suggestive association) or hip OA (with the aim of dis-
covering, de novo, loci associated with hip joint shape
that also contributed to hip OA susceptibility). This
study included 1) a univariate association analysis
between single SSM modes of proximal femur shape
and candidate SNPs and 2) a multivariate association
analysis between combined SSM modes of proximal
femur shape and candidate SNPs.
PATIENTS AND METHODS
Samples. Anteroposterior (AP) pelvic radiographs were
available from 2,224 subjects with hip OA recruited in stage 2 of
the Arthritis Research UK Osteoarthritis Genetics (arcOGEN)
Consortium genome-wide association study (GWAS) (18). A
list of the arcOGEN Consortium Investigators is provided in
Appendix A.
Inclusion criteria and ethical approval for subject
recruitment were as previously described (18). As shown in
Figure 1, we selected radiographs of the OA-unaffected hip
joint (Kellgren/Lawrence score of ,2 [19]) in patients with
unilateral hip OA. The final data set comprised 929 unrelated
subjects (570 women and 359 men) of Caucasian origin with
AP pelvic radiographs on which the OA-unaffected proximal
femur was visible without any occlusions. Demographic data
for each of the 929 subjects included body mass index (BMI)
and age, the latter being defined as the age at first hip arthro-
plasty. BMI data were available for 546 women and 342 men,
age data were available for 551 women and 346 men, and both
BMI and age data were available for 528 women and 333 men.
Genotyping, imputation, and quality control. Quality-
controlled genotype data were available for each of the 929
subjects from the arcOGEN Consortium GWAS.
A total of 813 subjects had been genotyped on Illumina
Human610-Quad BeadChips (18), and 116 subjects had been
Figure 1. Overview of selection of study subjects from the Arthritis
Research UK Osteoarthritis Genetics (arcOGEN) Consortium genome-
wide association study data set. OA5osteoarthritis.
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genotyped on Illumina HumanOmniExpress BeadChips (20).
Quality control at the subject and SNP levels was performed as
previously described (18,20). For the 116 subjects genotyped on
the HumanOmniExpress platform, imputed data were available.
The imputation had been performed with IMPUTE2 version
2.1.2 on the European data from the 1000 Genomes Phase 1
interim release in December 2010 with files downloaded from
the IMPUTE2 web site (http://mathgen.stats.ox.ac.uk/impute/
data_download_1000G_2010_interim.html) (21). The imputation
was run with the default IMPUTE2 parameters except for using
a buffer size of 500 kb, an effective population size of 15,000, and
the fix_strand_g option. Postimputation quality control was per-
formed to ensure that all SNPs had an IMPUTE-info score of
.0.8 and a minor allele frequency (MAF) of .5%. We used
GTOOL (22) to convert the imputed genotype probabilities into
Plink (23) format by making hard genotype calls using a thresh-
old of$0.9.
For the analyses in this study, we pooled the directly
typed genotypes of the 813 subjects genotyped on the 610-
Quad platform and the imputed genotypes of the 116 subjects
genotyped on the HumanOmniExpress platform. We refer to
these below as the 2 arcOGEN genotype data sets.
Candidate SNPs associated with hip OA or hip mor-
phology. We systematically searched the literature to identify
SNPs that had been associated with either hip OA or proximal
femur morphology based on studies that were published up
until December 2013. We included SNPs for which evidence
of association had been confirmed at a genome-wide level
(P , 5.03 1028) as well as SNPs showing a suggestive associa-
tion as defined in the original study.
Supplementary Table 1 (available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/doi/
10.1002/art.39186/abstract) shows SNPs reported previously as
being associated with either hip OA or proximal femur mor-
phology. In total, we identified 42 SNPs as potential candidates
for this study. Sixteen of the 42 SNPs were available in both arc-
OGEN genotype data sets after quality control. For the remain-
ing candidate index SNPs, we identified 25 proxies (r2 or D0 .
0.85) that were present in both arcOGEN genotype data sets using
the linkage disequilibrium (LD) search on http://www.broadinsti-
tute.org/mpg/snap/ (24) based on the 1000 Genomes Pilot 1 data
set for the CEU population (Utah residents with ancestry from
northern and western Europe, from the collection of the Centre
d’Etude du Polymorphisme Humain [http://www.cephb.fr/en/]).
None of the original 42 candidate SNPs were in high LD with each
other. In the genetic association analyses in this study, we included
all candidate SNPs that were directly available for both arcOGEN
genotype data sets as well as SNPs that were in high LD with one
of the candidate SNPs and available for both data sets.
Supplementary Table 2 (available on the Arthritis &
Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.
1002/art.39186/abstract) provides an overview of all candidate
SNPs and summarizes the final 41 SNPs used in this study. For
the 116 subjects for whom imputed data were available, 27 of
the 41 SNPs were imputation basis SNPs, and all SNPs passed
postimputation quality control.
SSMs. Building an SSM is based on principal compo-
nents analysis (PCA) and results in a number of shape model
modes (6), with every mode defining a pattern of shape varia-
tion and all modes being orthogonal to each other. The first
SSM mode accounts for the largest shape variation in the data
set, the second mode for the largest amount of shape variation
still remaining, and so on. For the purpose of analysis of bone
shape variation, the inclusion of all SSM modes that together
describe 95% of shape variation is accepted in the field as an
appropriate cutoff to minimize noise (8,10,11).
For each radiograph, manual annotations were available
outlining the contour of the OA-unaffected proximal femur using
65 points as shown in Supplementary Figure 1 (available on the
Arthritis & Rheumatology web site at http://onlinelibrary.wiley.
com/doi/10.1002/art.39186/abstract). Based on these, we built 3
SSMs of the proximal femur: a mixed-sex SSM (mean6SD age
64.16 15.0 years, mean6SD BMI 27.46 7.9 kg/m2), a female
SSM (mean6 SD age 64.06 15.0 years, mean6SD BMI
27.76 8.2 kg/m2), and a male SSM (mean6 SD age 64.36 15.0
years, mean6 SD BMI 27.16 7.3 kg/m2). Each of the SSMs
provided a subject-specific value for every shape model mode,
describing the shape of the proximal femur based on the shape
variation present in the given population. We built separate
mixed-sex and sex-specific SSMs because of the difference in
hip joint shape between men and women (25,26) and so that
selected candidate SNPs that had been identified previously in
a sex-stratified cohort could be tested in a population of that
sex. For each SSM, 12 shape model modes explained 95% of
the overall shape variation. Supplementary Table 3 (available
on the Arthritis & Rheumatology web site at http://onlinelibrary.
wiley.com/doi/10.1002/art.39186/abstract) summarizes the per-
centage of shape variation explained by each mode in every
model. We used the Kolmogorov-Smirnov test to verify that the
data for each mode and every model were normally distributed.
Univariate SNP association analysis. We performed
a univariate SNP association analysis by testing each SNP in the
population where the original association had been found (i.e.,
mixed-sex, female, or male) and using the shape model mode
values of the appropriate SSM. Hence, we tested each SNP for
only 1 of the 3 sex subsets as specified in Supplementary Table
2 (available on the Arthritis & Rheumatology web site at http://
onlinelibrary.wiley.com/doi/10.1002/art.39186/abstract). All as-
sociations between the shape modes and genotypes were esti-
mated using linear regression (Plink command –linear) in an
additive genetic model in Plink version 1.07 (23).
To determine empirically the significance of the linear
regression results, we performed 100,000 max(T) permutation
tests independently for each SNP, randomly reassigning the phe-
notypes to each individual (Plink command –mperm). This
resulted in 2 empirical estimates of significance for every test, a
pointwise P value of the individual SNP (Plink variable EMP1)
and a familywise P value that was corrected for all comparisons
(Plink variable EMP2). The latter is a more stringent criterion
for significance, and we considered SNPs with a familywise
P value of less than 0.05 to show a statistically significant associa-
tion. We also adjusted significance levels using the traditional
Bonferroni correction when accounting for all SNPs and SSM
modes tested. We used Quanto version 1.2.4 (27) to calculate
power estimates for our univariate analyses following an additive
genetic model and assuming a Type I error rate of 5%.
Multivariate SNP association analysis. We consid-
ered all shape model modes of an SSM to represent a multi-
variate phenotype and performed multivariate tests of
association to identify SNPs that contribute to the shape of the
proximal femur. We tested all SNPs for their association with
a combination of all shape model modes of the appropriate
SSM (i.e., mixed-sex, female, or male) using the multivariate
test of association implemented in Plink version 1.06p (28)
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(available from http://genepi.qimr.edu.au/staff/manuelF/
multivariate/main.html). This implementation is based on
canonical correlation analysis and tests for linear combinations
of all phenotypes (in our case SSM modes) that are most asso-
ciated with the genotype at the SNP. When performing permuta-
tion tests using the multivariate test of association implemented
in Plink, only pointwise, but not familywise, P values are re-
ported. Therefore, we estimated the significance level of our
multivariate results using traditional Bonferroni correction,
which accounted for all 41 SNPs tested. We considered SNPs
with a P value of less than 0.001 to show a statistically significant
association. All plots and calculations were made using custom
code developed in C11 and MatLab R2012a.
RESULTS
SNP association analysis using univariate shape
data. Of the 41 SNPs, 25 were tested against the mixed-
sex SSM modes, 8 against the female SSM modes, and
8 against the male SSM modes (see Supplementary
Table 2, available on the Arthritis & Rheumatology web
site at http://onlinelibrary.wiley.com/doi/10.1002/art.39186/
abstract). The familywise P values are diagrammatically
represented in Figure 2 for all SNPs before adjustment
for age and BMI. The figure shows that before adjust-
ment for covariates, 3 SNPs (rs6976, rs4836732, and
rs5009270) had a familywise P value of less than 0.05
and 1 SNP (rs12901499) had a familywise P value of less
than 0.052 when tested using 100,000 permutations
following an additive genetic model. After adjustment
for age and BMI, only rs4836732 remained significant at
a familywise significance level of less than 0.05 (see
Table 1). However, following Bonferroni correction for
all 492 tests (41 SNPs, 12 SSM modes), none of the
identified signals reached the expected pointwise signifi-
cance level of less than 0.0001 before or after adjust-
ment for age and BMI.
Analysis of the mean SSM mode values per geno-
type for the above SNPs revealed that the effect caused
by rs6976 on the values of SSM mode 7 might not be
additive (mean mode value for T/T, 20.0012; for T/C,
20.0011; and for C/C, 0.0020). Therefore, we tested
rs6976 for association with SSM mode 7 in the mixed-sex
model assuming dominance for the minor allele (Plink com-
mand –dominant). Following a dominant model, rs6976
was significantly associated with SSM mode 7 before and
after adjustment for age and BMI (see Table 1).
Two of the 3 SNPs in Table 1 were previously
reported as being associated with hip OA–related joint
replacement (rs6976 and rs4836732), and the other SNP
Figure 2. Familywise P values for all 492 tests (41 single-nucleotide polymorphisms [SNPs], 12 statistical shape model [SSM] modes) for associa-
tion between univariate SSM modes of the proximal femur and candidate SNPs. All familywise P values are before adjustment for covariates
and were obtained by running 100,000 permutations. The expected level for significance was a familywise P value of less than 0.05, which is indi-
cated by the dashed line. Three SNPs (rs6976, rs5009270, and rs4836732) reached this significance level and 1 SNP (rs12901499) was just above
it. Every SNP was tested following an additive genetic model in the stratum where the original association had been found (i.e., mixed-sex
[blue], female [green], or male [red]).
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Table 1. Association between univariate SSM modes of the proximal femur and SNPs previously
reported to be associated with hip osteoarthritis or hip morphology*
SNP/chromosome
Pointwise
P
Familywise
P
Sex
subset
SSM
mode
Minor
allele MAF
Before adjustment for
covariates
rs6976/3 0.00096 0.02355 Mixed 7 T 0.40
rs6976/3† 0.00028 0.00455 Mixed 7 T 0.40
rs5009270/7 0.0015 0.03742 Mixed 9 A 0.33
rs4836732/9 0.00159 0.01096 Female 5 T 0.48
After adjustment for
age and BMI
rs6976/3 0.00208 0.05025 Mixed 7 T 0.40
rs6976/3† 0.00091 0.02064 Mixed 7 T 0.40
rs5009270/7 0.00608 0.1278 Mixed 9 A 0.33
rs4836732/9 0.00493 0.03368 Female 5 T 0.48
* The expected level for significance was a familywise P value of less than 0.05. All results were
obtained running 100,000 permutation tests following an additive genetic model (if not stated other-
wise). SSM5 statistical shape model; SNPs5 single-nucleotide polymorphisms; MAF5minor allele fre-
quency; BMI5 body mass index.
† Results were obtained following a dominant, rather than an additive, genetic model.
Figure 3. Statistical shape model (SSM) modes associated with candidate single-nucleotide polymorphisms in this study from the univariate analy-
sis (A) and the multivariate analysis (B). “Female” and “mixed” refer to the SSM used in the association analysis. Each drawing shows the mean
(solid line)6 2.5 SD (dotted and dashed lines).
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was previously reported as being associated with hip OA
(rs5009270). Figure 3A shows the SSM modes for these 3
SNPs. The association of rs4836732 with mode 5 in the
female model indicates that this SNP might have an
effect on the superior orientation and size of the femoral
head. A similar picture is given by the association of
rs6976 with mode 7 in the mixed-sex model, although this
seems to represent overall femoral head size variation.
SNP association analysis using multivariate shape
data. Each SNP was tested for association with all 12
modes of the appropriate SSM (i.e., mixed-sex, female,
or male) simultaneously and following an additive gene-
tic model. None of the 41 SNPs reached the expected
significance level of less than 0.001 before or after adjust-
ment for age and BMI. The 5 SNPs with the lowest P
values (before/after adjustment for covariates) were
rs5009270 (0.02/0.03), rs4836732 (0.02/0.07), rs6976 (0.06/
0.13), rs1516893 (0.09/0.10), and rs12901499 (0.11/0.15).
All the remaining SNPs showed P values of greater than
0.2 before adjustment for covariates and of greater than
0.1 after adjustment for covariates.
We investigated the contribution of the individ-
ual SSM modes to the overall association for each of the
above 5 SNPs. Table 2 gives a summary of the individual
contributions. For each of the 5 SNPs, we then repeated
the multivariate analysis including only the 3 SSM
modes contributing the most (Table 2), as noncontribut-
ing modes might decrease rather than increase the
power of the multivariate approach (29). We chose the
3 SSM modes contributing the most as in all cases their
contribution values were different from the remaining
loading values across all SNPs. The results are shown in
Table 3. Both rs5009270 and rs4836732 had P values of
less than 0.001 before adjustment for covariates, and
rs5009270 also reached this significance level after
adjustment for age and BMI. All multivariate tests were
performed following an additive genetic model, as other
genetic models are not currently included in the multi-
variate test of association in Plink. Therefore, the multi-
variate results for rs6976 might be undervalued since
the univariate analysis indicated a dominant effect of
this SNP on SSM mode 7.
Table 2. Absolute loading values of individual SSM modes for the 5 SNPs that showed the most significant association in the multivariate ana-
lysis, indicating the contribution of each SSM mode to this association
SSM mode
SNP 1 2 3 4 5 6 7 8 9 10 11 12
rs5009270 0.12 0.22 0.37* 0.46* 0.01 0.03 0.01 0.29 0.64* 0.26 0.14 0.02
rs4836732 0.06 0.04 0.01 0.34 0.66* 0.02 0.04 0.39* 0.12 0.26 0.20 0.42*
rs6976 0.16 0.12 0.16 0.12 0.39* 0.26 0.73* 0.12 0.25 0.28* 0.08 0.07
rs1516893 0.20 0.09 0.34 0.09 0.16 0.16 0.63* 0.13 0.02 0.35* 0.49* 0.02
rs12901499 0.08 0.14 0.25 0.16 0.10 0.72* 0.40* 0.13 0.41* 0.07 0.02 0.18
* Indicates the 3 most contributing statistical shape model (SSM) modes for each single-nucleotide polymorphism (SNP).
Table 3. Multivariate association between the 3 most contributing SSM modes of the proximal femur and
SNPs previously reported to be associated with hip osteoarthritis or hip morphology*
SNP/chromosome P
Sex
subset
SSM
modes
Minor
allele MAF
Before adjustment for
covariates
rs6976/3 0.00149 Mixed 5, 7, 10 T 0.40
rs5009270/7 0.00039 Mixed 3, 4, 9 A 0.33
rs4836732/9 0.00044 Female 5, 8, 12 T 0.48
rs1516893/9 0.00237 Mixed 7, 10, 11 A 0.12
rs12901499/15 0.00158 Mixed 6, 7, 9 A 0.44
After adjustment for
age and BMI
rs6976/3 0.00555 Mixed 5, 7, 10 T 0.40
rs5009270/7 0.00040 Mixed 3, 4, 9 A 0.33
rs4836732/9 0.00347 Female 5, 8, 12 T 0.48
rs1516893/9 0.00363 Mixed 7, 10, 11 A 0.12
rs12901499/15 0.00219 Mixed 6, 7, 9 A 0.44
* The expected level for significance after Bonferroni correction was a P value of less than 0.001. All results
were obtained following an additive genetic model. SSM5 statistical shape model; SNP5 single-nucleotide
polymorphism; MAF5minor allele frequency; BMI5 body mass index.
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Figure 3B shows the 3 SSM modes that contribute
to the significant association with rs5009270. This association
with SSM modes 3, 4, and 9 in the mixed-sex model indi-
cates that rs5009270 might have an effect on femoral
neck width. Supplementary Figure 2 (available on the
Arthritis & Rheumatology web site at http://onlinelibrary.
wiley.com/doi/10.1002/art.39186/abstract) shows the 3 SSM
modes that contribute to the association with each of
the remaining 4 SNPs.
DISCUSSION
We have identified 3 SNPs that are significantly
associated with proximal femur morphology in a cohort of
subjects with hip OA, before and after adjustment for age
and BMI. The SNP rs4836732 (within the ASTN2 gene)
was found to be associated with SSM mode 5 in a female
model following a univariate additive genetic association
analysis, the SNP rs6976 (within the GLT8D1 gene) was
found to be associated with SSM mode 7 in a mixed-sex
model following a univariate dominant genetic association
analysis, and the SNP rs5009270 (near the IFRD1 gene)
was found to be associated with the combination of SSM
modes 3, 4, and 9 in a mixed-sex model following a multi-
variate additive genetic association analysis. We also
repeated the univariate and multivariate analyses adjust-
ing for height in view of prior reports of an excess of
shared signals between height and OA (30). We found,
however, that none of the associations reported in Tables 1
and 3 were dependent on height (see Supplementary Tables
4 and 5, available on the Arthritis & Rheumatology web site
at http://onlinelibrary.wiley.com/doi/10.1002/art.39186/
abstract). Given that all 3 SNPs had previously been
reported to be associated with hip OA (18,20) and also
showed significant association with proximal femur shape
in the present study (a completely different study design
of SSM-based quantitative trait analysis), we hypothesize
that these SNPs contribute to hip OA susceptibility by
altering proximal femur morphology.
Investigating the shape variation explained by
the associated SSM modes suggests that rs5009270 con-
tributes to femoral neck width and that rs4836732 and
rs6976 contribute to femoral head size. The first finding
is consistent with previous findings which show that a
wider femoral neck is associated with hip OA (3). Fur-
thermore, both rs4836732 and rs6976 were found to be
associated with hip OA in subjects who had undergone
total joint replacement (18). With the increasing evi-
dence that total hip replacement can be predicted
based on radiographic proximal femur shape (inde-
pendently of radiographic hip OA at baseline)
(5,10,11), this supports our hypothesis that these SNPs
contribute to hip OA susceptibility by affecting proxi-
mal femur shape. The proposed functions of the genes
nearest to the associated SNPs were reviewed when first
identified (see Supplementary Table 1, available on the
Arthritis & Rheumatology web site at http://onlineli-
brary.wiley.com/doi/10.1002/art.39186/abstract), and no
further information has been published in support of
these genes as obvious candidates for proximal femur
morphology or hip OA. Further, it has not been con-
firmed which genes contribute to susceptibility as, for
example, rs6976 is in perfect LD with rs11177 (within
the GNL3 gene) in a gene-dense LD block (.30 genes)
(18). Therefore, it is not known at this stage what the
molecular basis might be for the association with proxi-
mal femur shape.
Our rationale for applying a phenotype-based mul-
tivariate approach to genetic association analysis was that,
if there is correlation between several components of a
multivariate phenotype and these contribute to a signal,
then the statistical power of the analysis may increase (15)
and lead to a reduction in multiple testing (29). By the def-
inition of PCA, all modes of an SSM are linearly inde-
pendent. However, this study was based on the
assumption that a subset of all modes of a model might be
correlated with respect to a specific genotype. Therefore,
to test this hypothesis, we performed multivariate SNP
association analyses by testing for association between a
genotype and a combination of SSM modes.
The identification of rs5009270 as associated with
a combination of SSM modes suggests that the effect of
proximal femur shape susceptibility SNPs may not be
limited to a single aspect of shape. Using combinations
of SSM modes in the analysis of radiographic bone shape
is a promising approach to uncover new associations with
disease and the underlying cause. All SNPs that were
suggestive in our univariate SNP association analysis
were also suggestive in our multivariate SNP association
analysis—where the SSM mode of association identified
in the univariate analysis was also the mode contributing
the most to the association in the multivariate analysis
(see loading values in Table 2). This confirms that the
multivariate analysis can be used to identify the main
SSM mode of association requiring just a single test per
SNP rather than testing each SNP for each SSM mode
individually. Once association is identified by the multi-
variate analysis, a further single univariate analysis for
the mode contributing the most can be performed to test
for the significance of the association. Hence, the multi-
variate analysis reduces the number of tests performed
and thereby increases the power of the analysis. In addi-
tion, the multivariate analysis may identify associations
that are not clearly attributable to a single SSM mode but
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rather to a combination of SSM modes—which would
not be identified by testing for individual SSM modes
only as in the univariate approach. Therefore, in future
studies of the underlying genetics of bone shape, we sug-
gest first using a multivariate approach to SNP association
analysis to identify potential SNPs and SSM modes of
association, followed by a univariate approach to investi-
gate and confirm the findings.
A limitation of this study is that it relies on AP
pelvic radiographs, which only give a 2-dimensional pro-
jection of the 3-dimensional proximal femur. The pro-
jected radiographic shape of the proximal femur may
vary due to subject positioning during image acquisition
(e.g., due to pelvic or leg rotation). Therefore, no defi-
nite conclusions can be drawn as to whether the observed
genotype–phenotype associations relate to the true physi-
cal shape and/or the projected radiographic shape, the
latter of which might be altered by disease (e.g., due to pain
or restricted movement). However, previous studies have
shown radiographic proximal femur shape to be a predictor
of the onset of hip OA before the presence of any clinical
or radiographic signs of disease (3,5,8). In addition, the
present study was conducted on proximal femurs that were
free of radiographic signs of hip OA. Thus, we hypothesize
that the identified susceptibility loci have an effect on proxi-
mal femur morphogenesis, resulting in altered proximal
femur shape that predisposes to hip OA.
Previously reported SSM-based genotype–phe-
notype associations of hip joint shape with SNPs in the
DIO2 and FRZB regions (12,13) were not replicated in
this study. The reasons for this might be that the SSMs
capture different aspects of hip joint shape, that the sig-
nificance of association in the original study had not
been corrected for multiple testing (for DIO2 variants
[12]), or that the current study was underpowered due
to sample size (for FRZB variants [13]). Since power to
detect any of the examined loci depends largely on their
anticipated effect size (and other parameters), which
were unknown (DIO2) or not standardized (FRZB), we
instead conducted theoretical power calculations for the
variants examined in our study. In these calculations, we
used as a guide the effect sizes of our reported associa-
tions with modes 5, 7, and 9. Our power calculations
showed that for these effect sizes, our univariate analyses
had.80% power to detect an association for SNPs with a
MAF of$0.25 at an alpha level of less than 0.05 across all
strata examined (see Supplementary Table 6, available on
the Arthritis & Rheumatology web site at http://onlineli-
brary.wiley.com/doi/10.1002/art.39186/abstract). We expect
modest increases in power for higher SSM mode numbers
since, according to the definition of PCA, the standard
deviation of the modes decreases with increasing mode
numbers. For example, all SNPs with power x to detect an
association with SSM mode 5 (assuming an effect size of
20.0029) will have power. x to detect an association with
SSM modes 6–12. It is noteworthy that the examined
effect sizes are representative of the typical small-to-
modest effect sizes that have been observed for all
robustly established hip OA loci to date.
This study was conducted on radiographs of the
OA–unaffected hip joint of subjects with unilateral hip
OA on the assumption that the OA–unaffected side is a
good predictor of the shape of the affected side before
disease. This assumption was based on our prior analy-
ses of the 2-dimensional radiographic shape of left and
right proximal femurs as captured by an SSM (31).
Assuming radiographic proximal femur symmetry (31)
before the onset of disease, this raises questions as to
what determines which side (left/right) will first develop
OA, whether carriers of the risk allele of a susceptibility
SNP are more prone to develop bilateral hip OA over
time, and at what stage the morphology of the femur
reflects changes as a consequence of disease rather than
a predisposition. Future longitudinal studies will be
needed to explore the interplay between genetically
determined proximal femur morphology and the onset/
progression of disease.
We have identified several significant and sug-
gestive associations between hip OA susceptibility
SNPs and radiographic proximal femur shape as cap-
tured by SSMs. Further replication would be advanta-
geous to boost power and provide validation of these
associations additional between robustly established hip
OA loci and proximal femur shape. In future studies of
bone shape, we suggest the use of a combination of
multivariate and univariate SNP association analyses
both to increase power and to enable the identification
of associations with a combination of shape model
modes. These methods and approaches can be applied
as further associations are reported for OA (for exam-
ple, as reported by Evans et al [32]). Functional studies
will also be needed to determine the causative nature
of the identified associations.
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APPENDIX A: THE arcOGEN CONSORTIUM
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Southampton, Southampton, UK; Fraser Birrell, Newcastle University,
Newcastle, UK; Andrew Carr, University of Oxford, Oxford, UK;
Kay Chapman, University of Oxford, Oxford, UK; Panos Deloukas,
Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK; Michael
Doherty, University of Nottingham, Nottingham, UK; Andrew McCaskie,
Newcastle University, Newcastle, UK; William E. R. Ollier, University
of Manchester, Manchester, UK; Ashok Rai, Worcestershire Acute
Hospitals NHS Trust, Worcester, UK; Stuart H. Ralston, University of
Edinburgh, Edinburgh, UK; Timothy D. Spector, King’s College London,
London, UK; Ana M. Valdes, King’s College London, London, UK;
Gillian A. Wallis, University of Manchester, Manchester, UK; J. Mark
Wilkinson, University of Sheffield, Sheffield, UK; and Eleftheria Zeggini,
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